Endocrine Pathology

@EndoPath

Official Twitter Page of the Endocrine Pathology Society and its companion journal, Endocrine Pathology #EndoPath #USCAP #EndoPathSociety #EndocrinePathology

link.springer.com/journal/12022

Joined March 2017

Pinned
Endocrine Pathology
@EndoPath
Apr 5, 2017
Interesting #EndoPath data? Send us your article! Fast turn around & expert reviewers! Make our journal your voice! link.springer.com/journal/12022
Endocrine Pathology
@EndoPath
Jun 13
Are gallbladder neuroendocrine tumors really aggressive? A new study in Endocrine Pathology suggests most GB-NETs are small, low-grade, and indolent, with tumor size and grade emerging as key predictors of metastatic risk.
Neuroendocrine Tumors of the Gallbladder: A Multicenter Case Series and Systematic Literature...
From link.springer.com
Endocrine Pathology
@EndoPath
Jun 13
How does adrenocortical carcinoma become metastatic? New research suggests that widespread chromosomal alterations occur early and are retained throughout tumor evolution, identifying chromosomal instability as a key driver! Read more:
link.springer.com
Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
Endocrine Pathology - The mechanisms underlying how adrenocortical carcinoma (ACC) progresses into a metastatic and lethal disease remain poorly understood. To address this, we performed...
Endocrine Pathology
@EndoPath
Jun 2
Is it time to move beyond the typical/atypical carcinoid classification? Using data from >700 pulmonary NETs, researchers developed a reproducible grading system (Ki-67 and mitotic count) that outperformed traditional histology in predicting outcome.
Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Dri...
From link.springer.com
Endocrine Pathology
@EndoPath
Jun 2
New molecular insights into GEPNET G3: Multi-omic profiling shows these tumors are biologically distinct from neuroendocrine carcinomas, retain features of well-differentiated NETs and harbor potentially actionable alterations in 25% of cases.
Molecular Profiling of Digestive Grade 3 Neuroendocrine Tumors Reveals a Shared Molecular Framework...
From link.springer.com